CA2879467C - Method for increasing implantation success in assisted fertilization - Google Patents

Method for increasing implantation success in assisted fertilization Download PDF

Info

Publication number
CA2879467C
CA2879467C CA2879467A CA2879467A CA2879467C CA 2879467 C CA2879467 C CA 2879467C CA 2879467 A CA2879467 A CA 2879467A CA 2879467 A CA2879467 A CA 2879467A CA 2879467 C CA2879467 C CA 2879467C
Authority
CA
Canada
Prior art keywords
endometrial
state
uterine
female subject
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2879467A
Other languages
English (en)
French (fr)
Other versions
CA2879467A1 (en
Inventor
Nathalie Ledee
Marie Petitbarat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATRICELAB INNOVE
Original Assignee
MATRICELAB INNOVE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MATRICELAB INNOVE filed Critical MATRICELAB INNOVE
Publication of CA2879467A1 publication Critical patent/CA2879467A1/en
Application granted granted Critical
Publication of CA2879467C publication Critical patent/CA2879467C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1089Design, preparation, screening or analysis of libraries using computer algorithms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/367Infertility, e.g. sperm disorder, ovulatory dysfunction
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
CA2879467A 2012-07-20 2013-07-19 Method for increasing implantation success in assisted fertilization Active CA2879467C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12177377.4 2012-07-20
EP12177377.4A EP2687851A1 (en) 2012-07-20 2012-07-20 Method for increasing implantation success in assisted fertilization
PCT/EP2013/065355 WO2014013079A1 (en) 2012-07-20 2013-07-19 Method for increasing implantation success in assisted fertilization

Publications (2)

Publication Number Publication Date
CA2879467A1 CA2879467A1 (en) 2014-01-23
CA2879467C true CA2879467C (en) 2021-11-09

Family

ID=48874275

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2879467A Active CA2879467C (en) 2012-07-20 2013-07-19 Method for increasing implantation success in assisted fertilization

Country Status (17)

Country Link
US (1) US10450561B2 (he)
EP (2) EP2687851A1 (he)
JP (1) JP6411340B2 (he)
CN (1) CN104603622B (he)
AU (1) AU2013291941B2 (he)
BR (1) BR112015001157B1 (he)
CA (1) CA2879467C (he)
DK (1) DK2877856T3 (he)
ES (1) ES2740548T3 (he)
HK (1) HK1210835A1 (he)
HU (1) HUE046835T2 (he)
IL (1) IL236824B (he)
PL (1) PL2877856T3 (he)
PT (1) PT2877856T (he)
RU (1) RU2730873C2 (he)
SI (1) SI2877856T1 (he)
WO (1) WO2014013079A1 (he)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107924707B (zh) * 2015-06-12 2022-04-19 格尼亚Ip控股私人有限公司 患者和生物样本识别和追踪的方法和系统
EP3356830B1 (en) * 2015-09-30 2022-06-15 Hudson Institute of Medical Research A method of treatment and prognosis
CN105784983B (zh) * 2016-01-13 2017-10-31 深圳中山生殖与遗传研究所 一种评估子宫内膜容受性的试剂盒及其使用方法
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
WO2020154706A1 (en) * 2019-01-25 2020-07-30 Fertility Lab Sciences, Llc Uterine endometrial fluid for prediction of success in fertility treatment
CN110042156B (zh) * 2019-04-22 2021-12-28 苏州亿康医学检验有限公司 一种判断子宫内膜容受性的方法及其应用
CN110148446B (zh) * 2019-05-21 2023-06-16 重庆市柏玮熠科技有限公司 Ivf样本核对系统
CN114599798A (zh) * 2019-06-25 2022-06-07 哈德逊医学研究所 预测子宫内膜容受性的方法
RU2732432C1 (ru) * 2020-03-31 2020-09-16 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ оценки эндометриальной дисфункции у женщин с первичным эндометриоз-ассоциированным бесплодием
CN111624354A (zh) * 2020-06-05 2020-09-04 佛山迪安医学检验实验室有限公司 一种诊断试剂盒及诊断方法
CN111772682B (zh) * 2020-07-10 2021-08-13 北京大学第三医院(北京大学第三临床医学院) 预测受试者出现卵巢储备新变化年限的系统和方法
CN111778326B (zh) * 2020-07-14 2021-10-22 和卓生物科技(上海)有限公司 用于子宫内膜容受性评估的基因标志物组合及其应用
RU2748191C1 (ru) * 2021-01-21 2021-05-20 Мекан Рахимбердыевич Оразов Способ определения степени выраженности хронического эндометрита у женщин с маточным фактором бесплодия после неудачного экстракорпорального оплодотворения в анамнезе (варианты)
EP4407626A1 (fr) * 2023-01-30 2024-07-31 Sofia Procédé de génération de recommandations diagnostiques et/ou thérapeutiques en fertilité

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004154B (el) * 2001-05-21 2003-02-20 Μεθοδος διερευνησης του ενδομητριου με εξετασεις που εφαρμοζονται επι του ιστου αποπεπτωκοτος ενδομητριου (ιστου περιοδου)
US7175990B2 (en) 2002-02-26 2007-02-13 The Regents Of The University Of California Method of determining endometrial receptivity
US20100150862A1 (en) * 2006-12-07 2010-06-17 Schering Corporation Methods of modulating maternal-fetal tolerance
BRPI0913924B1 (pt) * 2008-07-01 2020-02-04 Univ Leland Stanford Junior método para determinação da probabilidade de que um indivíduo do sexo feminino irá experimentar um evento de nascimento com vida
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2011000805A1 (en) * 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
WO2011147976A1 (en) * 2010-05-27 2011-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for assessing endometrium receptivity of a patient
CN102985926B (zh) * 2010-07-13 2016-11-02 尤尼维公司 不孕症治疗中评估多胎分娩风险的系统
RU2444315C1 (ru) * 2010-09-03 2012-03-10 Михаил Григорьевич Шнейдерман Способ повышения возможности удачной имплантации эмбриона к эндометрию полости матки

Also Published As

Publication number Publication date
AU2013291941B2 (en) 2019-05-02
RU2730873C2 (ru) 2020-08-26
BR112015001157A2 (he) 2017-08-15
PL2877856T3 (pl) 2019-11-29
ES2740548T3 (es) 2020-02-05
PT2877856T (pt) 2019-08-21
EP2687851A1 (en) 2014-01-22
HK1210835A1 (en) 2016-05-06
BR112015001157B1 (pt) 2022-03-29
EP2877856B1 (en) 2019-07-10
CN104603622B (zh) 2017-08-01
EP2877856A1 (en) 2015-06-03
JP2015531057A (ja) 2015-10-29
WO2014013079A1 (en) 2014-01-23
US10450561B2 (en) 2019-10-22
HUE046835T2 (hu) 2020-03-30
AU2013291941A1 (en) 2015-02-12
IL236824B (he) 2018-06-28
CN104603622A (zh) 2015-05-06
US20150184152A1 (en) 2015-07-02
CA2879467A1 (en) 2014-01-23
SI2877856T1 (sl) 2019-11-29
JP6411340B2 (ja) 2018-10-24
RU2016106004A (ru) 2017-12-08
DK2877856T3 (da) 2019-08-12

Similar Documents

Publication Publication Date Title
CA2879467C (en) Method for increasing implantation success in assisted fertilization
Zhang et al. Effect of body mass index on pregnancy outcomes in a freeze-all policy: an analysis of 22,043 first autologous frozen-thawed embryo transfer cycles in China
Ku et al. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study
Franasiak et al. Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts
Koot et al. Molecular aspects of implantation failure
Boomsma et al. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF
Denison et al. Maternal obesity, length of gestation, risk of postdates pregnancy and spontaneous onset of labour at term
Vural et al. Hormonal and functional biomarkers in ovarian response
Lédée et al. Levels of follicular G-CSF and interleukin-15 appear as noninvasive biomarkers of subsequent successful birth in modified natural in vitro fertilization/intracytoplasmic sperm injection cycles
Papanikolaou et al. Identification of the high-risk patient for ovarian hyperstimulation syndrome
Ashrafi et al. Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model
Liu et al. Endometrial thickness as a predictor of ectopic pregnancy in 1125 in vitro fertilization-embryo transfer cycles: a matched case–control study
Tola The association between in vitro fertilization outcome and the inflammatory markers of complete blood count among nonobese unexplained infertile couples
Dahan et al. The biochemical pregnancy loss rate remains stable up irrespective of age and differs in pattern from clinical miscarriages
Liu et al. Anti‐Müllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 4
Kaser et al. When is clomiphene or gonadotropin intrauterine insemination futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials
Huang et al. Low basal serum testosterone level is detrimental to the embryo implantation in the patients with severe endometriosis
Simpson et al. Peri‐implantation cytokine profile differs between singleton and twin IVF pregnancies
Løssl et al. Predictive value of plasma human chorionic gonadotropin measured 14 days after Day‐2 single embryo transfer
Wong et al. Do uterine natural killer cell numbers in peri-implantation endometrium predict hypertensive disorder in pregnancy in women with a history of reproductive failure?
Campitiello et al. Endometrial LGR7 expression and implantation failure
George et al. The role of reproductive immunology in recurrent pregnancy loss and repeated implantation failure
Kaser et al. When is treatment with clomiphene or gonadotropin IUI futile? Results of FASTT and FORT-T, two prospective randomized controlled trials
Dumancic et al. Histopathologic characteristics of term placentas in singleton pregnancies in women with endometriosis-related infertility after ART treatment: case-control study
Ma et al. The effect of female body mass index on cumulative live birth rate in women undergoing in vitro fertilization according to age

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180627